Cancer patients forced to cash in KiwiSaver to fund treatments

KiwiSaver is becoming less of a retirement fund, and more of a life saver for some cancer patients forced to use it to pay for treatments not funded or not available here. Robert Moffitt was diagnosed with blood cancer in 2022, and a specialist recommened Daratumumab, which isn't funded in New Zealand, costing hundreds of thousands of dollars, forcing him to cash in his KiwiSaver. Robert Moffit spoke to Lisa Owen.